Verastem Oncology presents two-year follow-up data on avutometinib and defactinib in recurrent low-grade serous ovarian cancer

DualityBio reports China NMPA acceptance of BLA for T-Pam for treatment of unresectable or metastatic HER2-positive breast cancer

Gan & Lee and JW Pharmaceutical sign licensing deal for Bofanglutide Injection in South Korea

Oricell Therapeutics completes USD110m pre-IPO financing

ArkBio completes first cohort dosing in Australian phase I trial of antiviral drug-Fc conjugate for influenza

Tempus expands oncology collaboration with Gilead to accelerate AI-driven R&D

Eli Lilly launches Foundayo weight‑loss pill in the US

AtaiBeckley reports rapid and durable Phase 2a responses to BPL‑003 in treatment‑resistant depression

Solvonis Therapeutics secures second US patent for PTSD compound series

GSK secures China approval for Exdensur to treat nasal polyp condition

Ondine Biomedical ICU study accepted by Journal of Critical Care

Alzinova partners with Amsterdam UMC to advance blood-based Alzheimer's diagnostic

Coiled Therapeutics reports enhanced efficacy for AO-252 and accelerates transition to dose expansion

CenExel appoints Dr. Sy Pretorius as CEO

IDEOlogy Health and West Cancer Center partner to advance patient-centred oncology education and care